Targeted Genome Editing in IPSC - From Disease Modelling Towards TherapyWednesday, 7 October 2015 at 09:00 Add to Calendar ▼2015-10-07 09:00:002015-10-07 10:00:00Europe/LondonTargeted Genome Editing in IPSC - From Disease Modelling Towards TherapyGenome Engineering in Hanover, GermanyHanover, GermanySELECTBIOenquiries@selectbiosciences.com TALENs and CRISPR/Cas9-based nucleases are powerful tools for targeted gene editing in primary cells. Our interest in applying designer nucleases for therapeutic applications allowed us to define parameters that affect the genome-wide specificity of these customized nucleases and to develop GMP-compatible protocols for genome engineering in human stem cells. |